Somatostatin Receptor Scintigraphy Findings in a Patient with Metastatic Gastrinoma and MEN 1 Syndrome | Zendy

Gözde Mütevelizade | Zendy; Mehmet Aydın | Zendy; Ahmet Sezer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Somatostatin Receptor Scintigraphy Findings in a Patient with Metastatic Gastrinoma and MEN 1 Syndrome

Author(s) -

Gözde Mütevelizade,

Mehmet Aydın,

Ahmet Sezer

Publication year - 2011

Publication title -

molecular imaging and radionuclide therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.292

H-Index - 7

eISSN - 2147-1959

pISSN - 2146-1414

DOI - 10.4274/mirt.021482

Subject(s) - gastrinoma , medicine , scintigraphy , pancreas , somatostatin , zollinger ellison syndrome , duodenum , somatostatin receptor , neuroendocrine tumors , metastasis , gastroenterology , gastrin , pathology , cancer , secretion

Liver metastases from neuroendocrine tumours frequently occur and significantly worsen their prognosis. Somatostatin receptor scintigraphy (SRS) is a valuable method for the detection of somatostatin receptor-positive lesions like gastrinoma. In this case report, the importance of SRS to localize the primary tumor and the spread of disease is emphasized in a patient with neuroendocrine liver metastases. A 45-year-old man was admitted to hospital with multiple liver metastasis of neuroendocrine carcinoma. Somatostatin receptor scintigraphy showed multiple intense radiotracer uptakes in the liver and a focal tracer uptake at the right side of the upper abdominal region corresponding to duodenum or pancreas. Elevated serum gastrin levels confirmed the gastrinoma diagnosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research